1
/
of
1
Elabscience
SKU:E-CL-M0618
Mouse SCCA2(Squamous Cell Carcinoma Antigen 2) CLIA Kit
Mouse SCCA2(Squamous Cell Carcinoma Antigen 2) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Mouse SCCA2 (Squamous Cell Carcinoma Antigen 2) CLIA Kit, a cutting-edge solution designed to facilitate accurate and efficient detection of SCCA2 in mouse samples. This advanced kit is meticulously crafted to meet the highest standards of quality and reliability, ensuring precise and reproducible results.
The Mouse SCCA2 CLIA Kit is specifically engineered for the detection of Squamous Cell Carcinoma Antigen 2, a crucial biomarker associated with squamous cell carcinoma. With its state-of-the-art technology, this kit enables researchers and clinicians to gain valuable insights into the presence and levels of SCCA2 in mouse samples, aiding in the diagnosis and monitoring of squamous cell carcinoma.
This comprehensive kit includes all the necessary components for a seamless and streamlined workflow. It comprises of high-quality reagents, including pre-coated microplates, standards, controls, and detection antibodies, meticulously optimized to ensure optimal performance and sensitivity. The assay procedure is straightforward, allowing for easy implementation and minimal hands-on time.
The Mouse SCCA2 CLIA Kit offers exceptional sensitivity and specificity, enabling the detection of SCCA2 even at low concentrations. Its wide dynamic range ensures accurate quantification across a broad spectrum of sample concentrations, providing researchers with reliable and precise data.
Furthermore, this kit adheres to the highest industry standards, complying with the Clinical Laboratory Improvement Amendments (CLIA) regulations. Its robust design and rigorous quality control measures guarantee consistent and dependable results, making it an indispensable tool for research laboratories, diagnostic centers, and clinical settings.
In summary, the Mouse SCCA2 CLIA Kit is a state-of-the-art solution for the detection of SCCA2 in mouse samples. With its exceptional sensitivity, specificity, and adherence to CLIA regulations, this kit empowers researchers and clinicians with reliable and accurate data, facilitating advancements in the understanding and management of squamous cell carcinoma.
The Mouse SCCA2 CLIA Kit is specifically engineered for the detection of Squamous Cell Carcinoma Antigen 2, a crucial biomarker associated with squamous cell carcinoma. With its state-of-the-art technology, this kit enables researchers and clinicians to gain valuable insights into the presence and levels of SCCA2 in mouse samples, aiding in the diagnosis and monitoring of squamous cell carcinoma.
This comprehensive kit includes all the necessary components for a seamless and streamlined workflow. It comprises of high-quality reagents, including pre-coated microplates, standards, controls, and detection antibodies, meticulously optimized to ensure optimal performance and sensitivity. The assay procedure is straightforward, allowing for easy implementation and minimal hands-on time.
The Mouse SCCA2 CLIA Kit offers exceptional sensitivity and specificity, enabling the detection of SCCA2 even at low concentrations. Its wide dynamic range ensures accurate quantification across a broad spectrum of sample concentrations, providing researchers with reliable and precise data.
Furthermore, this kit adheres to the highest industry standards, complying with the Clinical Laboratory Improvement Amendments (CLIA) regulations. Its robust design and rigorous quality control measures guarantee consistent and dependable results, making it an indispensable tool for research laboratories, diagnostic centers, and clinical settings.
In summary, the Mouse SCCA2 CLIA Kit is a state-of-the-art solution for the detection of SCCA2 in mouse samples. With its exceptional sensitivity, specificity, and adherence to CLIA regulations, this kit empowers researchers and clinicians with reliable and accurate data, facilitating advancements in the understanding and management of squamous cell carcinoma.
Share
